Skip to Content

Watson 370 10 mg (Loxapine Succinate 10 mg)

Pill with imprint Watson 370 10 mg is White & Yellow, Capsule-shape and has been identified as Loxapine Succinate 10 mg. It is supplied by Watson Laboratories, Inc..

Loxapine is used in the treatment of agitated state; agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 370 10 mg

Loxapine succinate 10 mg Watson 370 10 mg
Loxapine succinate 10 mg Watson 370 10 mg
Loxapine succinate 10 mg Watson 370 10 mg

Loxapine Succinate

Imprint
Watson 370 10 mg
Strength
10 mg
Color
White & Yellow
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antipsychotic agents
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
lactose anhydrous, benzyl alcohol, butylparaben, edetate calcium disodium, gelatin, magnesium stearate, methylparaben, polacrilin potassium, propylparaben, sodium lauryl sulfate, sodium propionate, magnesium silicate, titanium dioxide, D&C Yellow No. 10, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-0370 Watson Pharmaceuticals, Inc.
51079-0901 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.